The first stop for professional medicines advice

Medicines planning

60 results

RelevanceNewest firstOldest firstTitle
Applied filters

Legal mechanisms and contrast agents

15 July 2024

Labelling medicines supplied without a prescription

9 September 2020Advice on the legal labelling requirements for Prescription Only Medicines (POM) and and Pharmacy Medicines (P) supplied under a PGD.

Inclusion of dose ranges in a single Patient Group Direction

9 September 2020The below summarises the considerations required if a single PGD is to include a range of doses.

Including more than one medicine in a Patient Group Direction

2 December 2021This article summarises the considerations required if more than one medicine is included within a PGD.

Including medicines with Risk Minimisation Measures (RMM) in PGDs

16 March 2021This article reflects MHRA guidance on the use of PGDs for medications which have risk minimisation measures (RMM).

Implementing ustekinumab biosimilar

4 September 2024

How to develop a Patient Group Direction

9 June 2022A step by step guide to help organisations and individuals navigate all stages of the PGD development process

Guidance Handling of Monoclonal Antibody (mAb) and Products (Yellow Cover)

16 December 2016Variation in practice underlined the need for an evidence-based guideline for handling mAbs that was suited to all those providing care to NHS patients.

Good governance when implementing ustekinumab biosimilar

2 August 2024

Good governance when implementing tocilizumab biosimilar

5 March 2024